ImmunoPrecise Antibodies IPA is preparing to release its quarterly earnings on Friday, 2025-03-28. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect ImmunoPrecise Antibodies to report an earnings per share (EPS) of $-0.06.

Investors in ImmunoPrecise Antibodies are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings History Snapshot

Last quarter the company missed EPS by $0.02, which was followed by a 5.09% drop in the share price the next day.

Here's a look at ImmunoPrecise Antibodies's past performance and the resulting price change:

Stock Performance

Shares of ImmunoPrecise Antibodies were trading at $0.4275 as of March 26. Over the last 52-week period, shares are down 72.78%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for ImmunoPrecise Antibodies visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.